• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Another sudden death in a child treated with desipramine.

作者信息

Riddle M A, Geller B, Ryan N

机构信息

Yale University School of Medicine, New Haven, CT.

出版信息

J Am Acad Child Adolesc Psychiatry. 1993 Jul;32(4):792-7. doi: 10.1097/00004583-199307000-00013.

DOI:10.1097/00004583-199307000-00013
PMID:8340300
Abstract

The sudden death of three children receiving the tricyclic antidepressant medication desipramine for behavioral disorders was reported in 1990. We now provide new information about these children and describe a fourth case. Because desipramine is a useful medication for many children, these deaths pose clinical dilemmas for physicians and families. The cardiac long QT syndrome has been proposed as a mechanism for these sudden deaths. Considerable uncertainty remains about the basis of the apparent association between the use of desipramine and the sudden deaths.

摘要

相似文献

1
Another sudden death in a child treated with desipramine.
J Am Acad Child Adolesc Psychiatry. 1993 Jul;32(4):792-7. doi: 10.1097/00004583-199307000-00013.
2
Stimulants and sudden death: what is a physician to do?兴奋剂与猝死:医生该怎么做?
Pediatrics. 2006 Sep;118(3):1215-9. doi: 10.1542/peds.2006-0942.
3
Sudden death in children treated with a tricyclic antidepressant.接受三环类抗抑郁药治疗的儿童猝死。
Med Lett Drugs Ther. 1990 Jun 1;32(819):53.
4
Clinical and neuropsychological effects of desipramine in children with attention deficit hyperactivity disorder.去甲丙咪嗪对注意力缺陷多动障碍儿童的临床及神经心理学影响。
J Clin Psychopharmacol. 1991 Jun;11(3):155-9.
5
Tricyclic medication in children and the QT interval: case report and discussion.儿童三环类药物与QT间期:病例报告与讨论
Can J Psychiatry. 1995 Aug;40(6):325-9.
6
Sudden death in children receiving Norpramin: a review of three reported cases and commentary.接受去甲丙咪嗪治疗的儿童猝死:三例报告病例综述及评论
J Am Acad Child Adolesc Psychiatry. 1991 Jan;30(1):104-8. doi: 10.1097/00004583-199101000-00016.
7
[Medication for ADHD and the risk of cardiovascular mortality].[用于治疗注意力缺陷多动障碍的药物与心血管疾病死亡率风险]
Ned Tijdschr Geneeskd. 2006 Aug 5;150(31):1713-4.
8
ECG changes in pediatric patients on tricyclic antidepressants, desipramine, and imipramine.使用三环类抗抑郁药、地昔帕明和丙咪嗪的儿科患者的心电图变化。
Can J Psychiatry. 1996 Mar;41(2):102-6. doi: 10.1177/070674379604100207.
9
Stimulant-drug therapy for attention-deficit disorder (with or without hyperactivity) and sudden cardiac death.用于治疗注意力缺陷障碍(伴或不伴多动)的兴奋剂药物疗法与心源性猝死
Pediatrics. 2007 Jan;119(1):154-5. doi: 10.1542/peds.2006-2467.
10
A naturalistic study of 24-hour electrocardiographic recordings and echocardiographic findings in children and adolescents treated with desipramine.
J Am Acad Child Adolesc Psychiatry. 1993 Jul;32(4):805-13. doi: 10.1097/00004583-199307000-00015.

引用本文的文献

1
The cardiovascular safety of tricyclic antidepressants in overdose and in clinical use.三环类抗抑郁药在过量服用及临床使用中的心血管安全性。
Ther Adv Psychopharmacol. 2024 May 30;14:20451253241243297. doi: 10.1177/20451253241243297. eCollection 2024.
2
Comprehensive systematic review summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders.全面系统综述总结:抽动障碍患者和慢性抽动障碍患者的治疗方法。
Neurology. 2019 May 7;92(19):907-915. doi: 10.1212/WNL.0000000000007467.
3
Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.
患有共病抽动障碍的儿童注意力缺陷多动障碍(ADHD)的药物治疗。
Cochrane Database Syst Rev. 2018 Jun 26;6(6):CD007990. doi: 10.1002/14651858.CD007990.pub3.
4
State-of-the-Art Review on Physiologically Based Pharmacokinetic Modeling in Pediatric Drug Development.儿科药物开发中基于生理的药代动力学建模的最新技术综述。
Clin Pharmacokinet. 2019 Jan;58(1):1-13. doi: 10.1007/s40262-018-0677-y.
5
Caregivers' Priorities and Observed Outcomes of Attention-Deficit Hyperactivity Disorder Medication for Their Children.照顾者对其子女注意缺陷多动障碍药物治疗的优先事项和观察结果。
J Dev Behav Pediatr. 2018 Feb/Mar;39(2):93-100. doi: 10.1097/DBP.0000000000000530.
6
Development and Qualification of Physiologically Based Pharmacokinetic Models for Drugs With Atypical Distribution Behavior: A Desipramine Case Study.具有非典型分布行为药物的生理药代动力学模型的开发与验证:地昔帕明案例研究
CPT Pharmacometrics Syst Pharmacol. 2017 May;6(5):315-321. doi: 10.1002/psp4.12180. Epub 2017 Apr 11.
7
Central Stimulant Treatment of Childhood Attention Deficit Hyperactivity Disorder : Issues and Recommendations from a US Perspective.中枢兴奋剂治疗儿童注意缺陷多动障碍:来自美国的观点、问题和建议。
CNS Drugs. 1997 Apr;7(4):264-72. doi: 10.2165/00023210-199707040-00002.
8
A systematic review of randomized controlled trials of bupropion versus methylphenidate in the treatment of attention-deficit/hyperactivity disorder.一项关于安非他酮与哌甲酯治疗注意缺陷多动障碍的随机对照试验的系统评价。
Neuropsychiatr Dis Treat. 2014 Aug 1;10:1439-49. doi: 10.2147/NDT.S62714. eCollection 2014.
9
Cardiologic side effects of psychotropic drugs.精神药物的心脏毒性作用。
J Geriatr Cardiol. 2011 Dec;8(4):243-53. doi: 10.3724/SP.J.1263.2011.00243.
10
The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders.冲动控制障碍的药理学治疗的大鼠模型冲动性的效用。
Br J Pharmacol. 2011 Oct;164(4):1301-21. doi: 10.1111/j.1476-5381.2011.01323.x.